Please sign in to follow a disease.
Small cell carcinoma
MONDO:0000402A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble "oat cells" under the microscope. Small cell carcinoma most often affects the lungs. Clinically, this is often a rapidly growing cancer that spreads to distant sites early.
Also known as: oat cell cancer, oat cell carcinoma, small cell NEC, small cell cancer, small cell car. (extrapulmonary), small cell carcinoma, small cell carcinoma (extrapulmonary), small cell neuroendocrine carcinoma
3255 clinical trials for this condition and its sub-types, 26 tagged with Small cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Small cell carcinoma
-
Small cell lung carcinoma 514 trials · 515 incl. sub-types
2 sub-types
-
Prostate small cell carcinoma 9 trials
-
Cervical small cell carcinoma 4 trials
-
Ovarian small cell carcinoma 1 trial · 2 incl. sub-types
2 sub-types
-
Ureter small cell carcinoma 1 trial
-
Bartholin gland small cell carcinoma 0 trials
-
Endometrial small cell carcinoma 0 trials
-
Laryngeal small cell carcinoma 0 trials
-
Salivary gland small cell carcinoma 0 trials
-
Thymus small cell carcinoma 0 trials
Most studied deeper sub-types
-
Experimental drug duo aims to boost immune attack on tough cancers
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, obrixtamig and ZL-1310, designed to help the immune system fight cancer. It is for adults with advanced small cell lung cancer or other neuroendocrine cancers. The trial has two parts: the first finds a safe dose of the tw…
Phase 1/2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Could a 50-Year-Old antipsychotic drug shrink Hard-to-Treat cancers?
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with small cell lung or cervical cancer that has returned after at least two prior treatments. The goal is to see if the drug can shrink tumors or slow disease progression. Participants take the …
Phase 1/2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC